News

Low Vit D Linked to Higher Mortality in Type 2 Patients


 

SAN DIEGO — Adult patients with type 2 diabetes and severe vitamin D deficiency face a twofold increased risk of all-cause mortality, independent of urinary albumin excretion rate and conventional cardiovascular risk factors, results from a long-term observational study showed.

”A lot of people have insufficient levels of vitamin D without even knowing it,” Dr. Christel Joergensen, lead author, said in an interview during a poster session at the annual meeting of the American Society of Nephrology.

Dr. Joergensen of the Steno Diabetes Center, Gentofte, Denmark, and her associates followed 290 white patients with type 2 diabetes for a median of 15.5 years.

They defined severe vitamin D deficiency as the lower 10th percentile (below 13.9 nmol/L, corresponding to 34.7 ng/mL).

At baseline, patients' mean age was 54 years, 173 were normoalbuminuric, 73 had microalbuminuria, and 44 had macroalbuminuria. The median vitamin D level was 35.7 nmol/L.

During follow-up, 142 patients (49%) died. Of these, 102 (73%) died from cardiovascular causes. All-cause mortality was significantly increased in patients with severe vitamin D deficiency, an association that persisted after adjustment for urinary albumin excretion rate, glomerular filtration rate, hemoglobin A1c, and conventional cardiovascular risk factors.

Severe vitamin D deficiency was also significantly associated with cardiovascular mortality.

Dr. Joergensen cited the small number of patients as a study limitation. She had no financial conflicts to disclose.

Recommended Reading

Guideline-Recommended Care Reduces Diabetic Vision Problems
MDedge Endocrinology
Antidepressant Lowers HbA1c and Systolic BP
MDedge Endocrinology
Data Watch: Prevalence of Antidiabetic Medication Use Among U.S. Children and Adolescents
MDedge Endocrinology
Metabolic Syndrome Predicted Type 2 Diabetes in Japanese
MDedge Endocrinology
Insulin Pump Is Suitable for Many Diabetic Children
MDedge Endocrinology
Glucose Control Stagnates at Diabetes Camp
MDedge Endocrinology
Insulin Correction Dosing Refined by Using Weight
MDedge Endocrinology
Lifestyle Intervention Remains Effective at 10-Year Mark
MDedge Endocrinology
Ranibizumab Improves Acuity in Macular Edema
MDedge Endocrinology
Nuts, Dietary Pulses Improve Control in Type 2
MDedge Endocrinology